Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit

被引:67
作者
Darze, ES
Latado, AL
Guimaraes, AG
Guedes, RAV
Santos, AB
de Moura, SS
Passos, LCS
机构
[1] Hosp Alianca, Div Cardiol, Echocardiog Lab, BR-41920000 Salvador, BA, Brazil
[2] Hosp Portugues, Coronary Care Unit, Salvador, BA, Brazil
关键词
congestive heart failure; ICU; pulmonary embolism;
D O I
10.1378/chest.128.4.2576
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To determine the incidence of clinical pulmonary embolism (PE) in a population with severe congestive heart failure (CHF) admitted to a coronary care unit (CCU), and to identify clinical predictors of PE in this population. Design and setting: Prospective, observational study performed in a CCU of a tertiary care hospital between July 2001 and March 2003. Patients: One hundred ninety-eight patients with severe decompensated CHF. Measurements and results: Of 198 patients recruited, IS patients (9.1%) received a diagnosis of PE during their hospitalization. Deep vein thrombosis was demonstrated in 8 of IS patients (44.4%) with PE. Thromboprophylaxis was used by 12 of 18 patients (66.7%) with PE and 126 of 180 patients (70%) without PE (p = 0.77). Both groups were similar with respect to mean age (68.2 +/- 14.1 years vs 69.6 +/- 13.4 years [ +/- SD]), proportion of male patients (61.1% vs 55.1%), markers of CHF severity (New York Heart Association functional class > II, ejection fraction < 30%, Na < 136 mEq/L, ischemic etiology), and comorbid conditions (diabetes mellitus, atrial fibrillation, chronic renal failure, hypertension) [p = not significant]. The presence of PE was significantly associated with cancer (relative risk [RR], 8.4; 95% confidence interval [CI], 3.9 to 18.1), immobilization (RR, 5.4; 95% CI, 2.0 to 14.4), previous venous thromboembolism (VTE) [RR, 4.4; 95% CI, 1.7 to 11.3], COPD (RR, 3.1; 95% CI, 1.03 to 9.2), and right ventricle (RV) abnormality (RR, 3.3; 95% CI, 1.3 to 8.0). In a multiple logistic regression analysis, only cancer (odds ratio [OR], 26.9; 95% CI, 4.9 to 146.8), RV abnormality (OR, 9.7; 95% CI, 2.2 to 42.6), and previous VTE (OR, 9.1; 95% CI, 1.28 to 64.7) remained independently associated with PE. Conclusions: In patients with severe decompensated CHF admitted to a CCU, the incidence of clinical PE is very high despite adequate prophylaxis. Traditional risk factors seemed to play an important role in determining the risk of PE in this population.
引用
收藏
页码:2576 / 2580
页数:5
相关论文
共 24 条
[1]  
Ageno W, 2002, HAEMATOLOGICA, V87, P746
[2]   Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study [J].
Alikhan, R ;
Cohen, AT ;
Combe, S ;
Samama, MM ;
Desjardins, L ;
Eldor, A ;
Janbon, C ;
Leizorovicz, A ;
Olsson, CG ;
Turpie, AGG .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :963-968
[3]  
*AM HEART ASS, 2002, HEART DIS STROK STAT
[4]   Fatal pulmonary embolism in hospitalised medical patients [J].
Baglin, TP ;
White, K ;
Charles, A .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (07) :609-610
[5]   HIGH-RISK OF THE CRITICALLY ILL FOR VENOUS THROMBOEMBOLISM [J].
CADE, JF .
CRITICAL CARE MEDICINE, 1982, 10 (07) :448-450
[6]   Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD [J].
Fraisse, F ;
Holzapfel, L ;
Coulaud, JM ;
Simmoneau, G ;
Bedock, B ;
Feissel, M ;
Herbecq, P ;
Pordes, R ;
Poussel, JF ;
Roux, L .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1109-1114
[7]   SMALL SUBCUTANEOUS DOSES OF HEPARIN IN PREVENTION OF VENOUS THROMBOSIS [J].
GALLUS, AS ;
HIRSH, J ;
TUTTLE, RJ ;
TREBILCOCK, R ;
OBRIEN, SE ;
CARROLL, JJ ;
MINDEN, JH ;
HUDECKI, SM .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (11) :545-551
[8]   Prevention of venous thromboembolism in the ICU [J].
Geerts, W ;
Selby, R .
CHEST, 2003, 124 (06) :357S-363S
[9]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[10]   Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm -: Effects of angiotensin-converting enzyme inhibitor and β-blocker therapy [J].
Gibbs, CR ;
Blann, AD ;
Watson, RDS ;
Lip, GYH .
CIRCULATION, 2001, 103 (13) :1746-1751